Metagenomi Inc
NASDAQ:MGX
Cash Flow Statement
Cash Flow Statement
Metagenomi Inc
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
(93)
|
(68)
|
(93)
|
(75)
|
(74)
|
(78)
|
(78)
|
(87)
|
(89)
|
|
| Depreciation & Amortization |
5
|
4
|
5
|
5
|
5
|
5
|
5
|
6
|
5
|
|
| Stock-Based Compensation |
6
|
7
|
12
|
15
|
15
|
16
|
14
|
13
|
13
|
|
| Other Non-Cash Items |
(1)
|
(1)
|
4
|
13
|
14
|
23
|
21
|
23
|
23
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
|
| Change in Working Capital |
47
|
(26)
|
(37)
|
(43)
|
(49)
|
(60)
|
(51)
|
(38)
|
(31)
|
|
| Cash from Operating Activities |
(41)
N/A
|
(91)
-122%
|
(121)
-33%
|
(100)
+17%
|
(103)
-3%
|
(109)
-5%
|
(102)
+6%
|
(97)
+5%
|
(92)
+6%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(22)
|
(10)
|
(11)
|
(6)
|
(5)
|
(3)
|
(2)
|
(2)
|
(1)
|
|
| Other Items |
(115)
|
56
|
(38)
|
34
|
(52)
|
(85)
|
34
|
65
|
101
|
|
| Cash from Investing Activities |
(137)
N/A
|
46
N/A
|
(49)
N/A
|
29
N/A
|
(56)
N/A
|
(88)
-57%
|
31
N/A
|
63
+103%
|
100
+57%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
244
|
4
|
91
|
85
|
84
|
84
|
0
|
(0)
|
0
|
|
| Other |
(2)
|
(3)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
|
| Cash from Financing Activities |
242
N/A
|
1
-100%
|
88
+8 551%
|
81
-7%
|
83
+2%
|
84
+2%
|
(3)
N/A
|
(1)
+72%
|
(0)
+41%
|
|
| Change in Cash | ||||||||||
| Net Change in Cash |
64
N/A
|
(45)
N/A
|
(83)
-85%
|
10
N/A
|
(77)
N/A
|
(113)
-47%
|
(73)
+35%
|
(34)
+53%
|
8
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(63)
N/A
|
(101)
-60%
|
(132)
-30%
|
(106)
+20%
|
(108)
-2%
|
(112)
-4%
|
(105)
+7%
|
(99)
+5%
|
(92)
+7%
|
|